Clinical Trials Logo

Obesity, Childhood clinical trials

View clinical trials related to Obesity, Childhood.

Filter by:

NCT ID: NCT03537755 Recruiting - Obesity, Childhood Clinical Trials

Black Adolescent & Entertainment Study

Start date: June 6, 2017
Study type: Observational

The study is being conducted to obtain adolescent girls' thoughts and opinions on relationship and communication styles are shown on television.

NCT ID: NCT03533621 Completed - Obesity, Childhood Clinical Trials

Gut Microbiome, Adiposity, and Probiotics (GMAP)

Start date: September 4, 2014
Phase: N/A
Study type: Interventional

Recent studies have shown that the bacteria in the gut (gut microbiome) can affect adiposity levels and inflammation. In animal studies, changing these bacteria has been linked with decreased fat mass and inflammation as well as improved metabolism. Probiotics can be a safe method of altering the gut microbiome in humans and have shown promising results in adults with regards to changing adiposity and inflammatory markers. However, it may also be important to provide the right dietary milieu (i.e. high fruit and vegetable/low saturated fat diet) in order to see the benefits of probiotics on these physiologic markers. At this time, no one has offered probiotics in the context of the right dietary milieu and tested it in children. This pilot proposal is innovative because it will be the first to test how well probiotics work in the context of a diet high in fruits and vegetables to change the gut microbiome, decrease fat mass, and improve inflammatory markers in overweight/obese children. This protocol will allow one to better understand the effect of probiotics on these physiologic functions and determine acceptability and feasibility of taking daily probiotics.

NCT ID: NCT03529695 Not yet recruiting - Obesity Clinical Trials

In-home Obesity Prevention to Reach Low-income Infants

Start date: June 15, 2018
Phase: N/A
Study type: Interventional

Existing obesity prevention efforts have had limited success among underserved, low-income children. This study capitalizes on the strengths of a nationwide ongoing Home Visitation Program (HVP), which serves at-risk, low-income, ethnically/racially diverse mothers and their infants, to test the effectiveness of delivering obesity prevention as part of their weekly, in-home services. The study will evaluate whether the integration of an obesity prevention enhancement module into existing HVP services, reduces the risk and incidence of obesity and associated risk factors in mothers and infants, compared to the provision of standard home visitation services. The study also focuses on the role of maternal factors (maternal diet, physical activity, food insecurity and feeding practices) and social factors (social network support) as mechanisms operating on infant outcomes.

NCT ID: NCT03516968 Not yet recruiting - Obesity, Childhood Clinical Trials

Monthly Boluses Versus Daily Doses for Correcting Blood Vitamin D Deficit in Obese Children and Adolescents

Start date: September 2018
Phase: Phase 3
Study type: Interventional

Childhood obesity prevalence is increasing and is a serious public health challenge. Indeed, according to INPES in 2006, overweight and obesity were affecting 18 % of French children between 3 and 17 years. 3 % of the boys and 4 % of the girls were classified as obese. Obese children are likely to develop chronic disease, starting at paediatric age, as cardiovascular or bone diseases, or type 2 diabetes. Vitamin D deficiency is recognized to play an essential role in bone metabolism and arterial hypertension and type 2 diabetes development. Obesity, in adults like in children, is associated with vitamin D deficiency. Common explanations for this low serum concentration of 25(OH)D in obese are the sequestration and/or the volumetric dilution of this lipid-soluble vitamin by adipose tissue. Therefore, obese population is at higher risk of developing cardiovascular and metabolic complications. The nutrition comity of French Pediatric Society (SFP) edit vitamin D supplementation recommendations (2012) for adolescents at risk of deficit: supplementation by trimestral loading dose of 80 000 to 100 000 UI of vitamin D. However, for obese patients, the deficit is difficult to cure with classical loading doses. It seems that these patients need higher dose of Vitamin D (two to three times higher). Likewise, the optimum scheme of administration (daily vs monthly) was never evaluated. Given new physiopathological data on pleiotropic role of vitamin D (on bone, cardiovascular system, adipose tissue) and in light of consequence of obesity on these systems, it seems essential to obtain data on vitamin deficit correction in obese children and adolescents and to evaluate bone status of these patients using modern imaging technics (high resolution peripheral quantitative computed tomography, HRpQCT). In this context, the OBEVIDOS study, randomised multi-centre prospective in 156 obese children and adolescent will allow us for : - evaluate vitamin D correction effect by two scheme of administration - establish an inventory of vitamin D status in this population - Modeling and simulation of vitamin D concentration in obese children and adolescents using a mathematical PBPK model - study, in a patient sub-group, the impact of vitamin D deficit and of obesity by itself on bone, by analysing bone micro-architecture

NCT ID: NCT03510494 Completed - Physical Activity Clinical Trials

The Svendborg-project

Start date: August 2008
Phase: N/A
Study type: Interventional

The main aim of this study is to describe differences in development of health and motor performance over time in relation to type of school and other background variables.

NCT ID: NCT03508622 Recruiting - Obesity, Childhood Clinical Trials

Group Telehealth Weight Management Visits for Adolescents With Obesity

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

This pilot study aims to evaluate the feasibility and efficacy of a group telehealth model, compared with a standard multi-disciplinary, individualized, in-clinic weight management model, for treatment of adolescents with obesity.

NCT ID: NCT03500484 Recruiting - Obesity, Childhood Clinical Trials

Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.

Start date: June 6, 2018
Phase: Phase 2
Study type: Interventional

To study the effects of liraglutide on neural responses to high fructose corn syrup (HFCS) in individuals with obesity.

NCT ID: NCT03495583 Enrolling by invitation - Obesity, Childhood Clinical Trials

The EAT-On Study: Sensitisation, Allergy and Child Health

Start date: April 3, 2018
Phase: N/A
Study type: Interventional

The EAT Study showed a reduction in both sensitisation (to all foods) and clinical food allergy (to peanut and egg) among children who consumed allergenic food early compared with those who followed standard government feeding advice to exclusively consume breast milk for the first 6 months of life. The EAT-On Study aims to establish whether the effects seen at 3 years in the EAT study represent a delay in FA onset or sustained tolerance. EAT-On will also investigate the natural history (emergence and resolution) of FA in childhood; thus shaping dietary and management plans for allergic patients. Findings will inform future research and weaning recommendations for preventing FA.

NCT ID: NCT03495310 Not yet recruiting - Obesity, Childhood Clinical Trials

Effect of Mindfulness on Stress, Appetite Hormones and Body Weight of Obese Schoolchildren. Controlled Clinical Trial

Start date: May 9, 2018
Phase: N/A
Study type: Interventional

In addition to diet and sedentary lifestyle, factors such as stress, depression and anxiety have been found associated in up to 86% of cases of obesity in children. Mindfulness is a method based on the concentration of attention, awareness and meditation, which has been successfully used to reduce stress, depression and anxiety in individuals with some pathology in the short term (eight weeks). Objective: To determine if an intervention with mindfulness is effective to reduce the stress, appetite, and body weight of a group of school children with obesity and stress comparing them with a group that receives conventional therapy. Methods For a controlled clinical trial, 60 children of 10-14 years of age with obesity (BMI> 2 SD) and stress (Spence scale> 60) will be selected, and randomly assigned to a group that receives the intervention with mindfulness (M8S), or to the control group (TC);The intervention with Mindfulness will be done once a week for 8 weeks. Measurements of BMI, glucose, leptin, ghrelin, cortisol and insulin will be carried out at the beginning of the study, and repeated at the end of the intervention and eight weeks after finishing the intervention to evaluate relapses.

NCT ID: NCT03490448 Completed - Clinical trials for Vitamin D Deficiency

The Changes of Body Composition, Glucolipid Metabolism and Bone Metabolism in Obese Children After Weight Loss

Start date: July 6, 2014
Phase: N/A
Study type: Interventional

Vitamin D plays a significant role in calcium and phosphorus homeostasis for maintaining structural integrity and function of musculoskeletal system. Furthermore, recent studies have revealed that vitamin D can decrease the risk of many conditions other than skeletal disease, including autoimmune diseases, cancers, obesity and obesity-related diseases, such as type 2 diabetes and cardiovascular disease. Vitamin D may influence calcium absorption to affect obesity indirectly, regulate adipocyte differentiation and relieve the development of metabolic syndrome by mediating levels of inflammatory factors. Another indicator of bone metabolism—osteocalcin may also be involved in energy metabolism and glucose metabolism, and undercarboxylated osteocalcin (ucOC) is the form which has physiological activity. ucOC may recombine with the receptors on the surface of pancreas β cells, adipocytes, hepatocytes and intestinal endocrine cell to regulate insulin secretion and insulin sensitivity. Currently, the prevalence of vitamin D deficiency is a global problem in all age groups currently, even in countries with sun exposure all year around. The obesity group tend to have a higher incidence of vitamin D deficiency.Moreover, the obesity group tend to have a higher incidence of vitamin D deficiency and a lower level of serum osteocalcin. This study observed the changes of body composition and glucolipid metabolism and bone metabolism during weight loss, and investigated the correlations among them.